"The source for European pharmaceutical biotechnology news..."
New Account

The Magazine

Issue 2

Issue 2 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Platinum Sponsors

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
25 May 2011

Focus Areas

Cover Stories

Chips in

Why falling costs and maturing technology mean biochips can revolutionise drug discovery.

Producing the goods

Looking at the new manufacturing principles squeezing more value out of pharma.

India calling

India is often thought of as the hub for industrial outsourcing. But is it right for pharma? Rob Plastow has been looking the impact on...

Roundtables

  • The Executive Roundtable

    Kevin Hrusovsky of Caliper Life Sciences, Nick Hughes from PA Consulting Group, David Weber of Stratagene, and Whatman's Dr Jens Beator offer their views on pharma's...
    Read more

Vendor Perspectives

Industry Analysts

  • Banking on it

    Despite growing interest, biobank use still faces a number of hurdles – from IT to governance. Will we ever fully realise the full potential of these hugely important...
    Read more
  • Higher learning

    Steven Rauschkolb of the Society of Pharmaceutical and Biotech Trainers explains how the training sector has evolved to ensure you can get the best out of your staff.
    Read more
  • The PAT initiative: a real-time insight

    Quality control is a major issue in pharmaceutical manufacturing. With the Process Analytical Technology initiative, the FDA is striving for greater efficiency and cost...
    Read more
  • Advances in bioreactor agitation

    In the critical part of scaling up a cell culture system it is often found that insufficient attention is given in bid specifications to the bioreactor agitator. By Neil...
    Read more

Executive Interviews

The content and compliance issue

Kevin O'Leary of QUMAS finds a way through the mess.
Read more

Bioinformatics

Bioinformatics is playing an increasingly important role in drug development and our understanding of complex genetic and molecular information. Simon Smith, Head of Bioinformatics, J&J talks to NGP about growth and potential breakthroughs.
Read more

Informatics

With Professor Antony N. Davies, Waters Informatics
Read more

NGP Europe Summit: Drug Discovery

NGP Europe Summit: Drug Discovery
5th - 7th April 2011

The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.